The Eurofins U.S. clinical diagnostics network has been at the forefront of COVID-19 testing – launching its first RT-PCR assay for SARS-CoV-2 on March 13.  Since then, Eurofins has rolled out several highly sensitive and specific assays to thousands of clients nationwide, including hospitals, physicians' offices, nursing homes, government entities, sports organizations and employers.  At-Home COVID-19 testing adds additional capability, alongside pooled, antibody, wastewater, used-mask, saliva and combined COVID-19, Influenza and RSV tests. Updated daily, our test guide provides direct access to information on all of the tests offered at Eurofins Biomnis, including preanalytical information, methodologies, clinical significance, forms to be included, stability…. 1,940 new COVID-19 cases, 23 more deaths in Ontario. There was an error processing your request. Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Since March, Eurofins US clinical diagnostic testing capacity has ramped up to over 500,000 samples per week.  Recent turnaround time for results has averaged less than 18 hours from specimen receipt in the lab. Q&A – COVID-19. Viracor Eurofins is providing COVID-19 testing for transplant programs, large hospital systems and local hospital systems such as Saint Luke's and Truman Medical Centers. The company is based outside of Boston, in Framingham, MA. Eurofins' innovative COVID-19 assays include: EUA-authorized At-Home COVID-19 PCR Test Kit, pooled, antibody, wastewater, worn-mask, and saliva tests. empowerDX is the online shop for easy at-home health testing. Coronavirus test crisis as kits shipped in from Europe found contaminated with COVID-19 BORIS JOHNSON'S attempts to role out a programme of mass coronavirus testing have suffered a … This home-collection kit has not been FDA cleared or approved; rather it has been authorized by FDA under an EUA only for the self-collection and maintenance of nasal swab specimens as an aid in detection of nucleic acid from SARS-CoV-2, and not for any other viruses or pathogens, and only for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in medical devices during the COVID-19 outbreak under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. Viracor's nasal test … Error! Brussels Airport will carry out four times more coronavirus tests at its testing centre from Friday, the private laboratory Eurofins announced on Thursday. Arriving passengers: do you live in Belgium, are you older than 6 years and have you stayed in a red zone for more than 48 hours? Ontario reported 1,940 new cases of coronavirus on Monday, marking the second highest single-day increase, to … To learn more, please visit empowerdxlab.com. Its R&D teams located at various sites around the world share their expertise in developing a wide range of innovative methods and applications with a focus on immunoassays and molecular testing. Eurofins (Paris:ERF) announces that its FDA-authorized At-Home COVID-19 Nasal PCR Test is now being covered by Medicare, Medicaid and commercial insurance providers. In contrast to nasopharyngeal swabs, gargling is a non-invasive, easy-to-use sampling method that is less uncomfortable for the patient and particularly useful for self-sampling applications and the testing of children. For more information, please visit www.eurofins.com. As one of the most innovative and quality-oriented international groups in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the increasing demands of regulatory authorities and healthcare practitioners around the world. … The multiplex PCR test allows for a streamlined workflow in one reaction and provides results in approximately one hour. Eurofins U.S. Clinical Diagnostic Laboratories At-Home COVID-19 Test Now Being Offered in All 50 States, Stormcenter - School / Business Application, https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-reference-panel-comparative-data, History's Headlines: Frederick Douglass, freedom fighter for all, Man ejected from vehicle in Carbon County crash, Alvernia University professors weighs in on Twitter ban of President Trump, Lasorda, fiery Hall of Fame Dodgers manager, dies at 93, 14 Pennsylvanians among those arrested after violent protests at U.S. Capitol, Police charge man in killing of prominent Bensalem chiropractor, Democrats plan lightning Trump impeachment, want him out now, Local dieticians give advice on how to lose weight and keep it off, Twitter bans Trump, citing risk of incitement of violence, State lawmaker charged after entering Capitol with rioters. Find the answers of our expert biologists to your questions about COVID-19. Shares in Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0014000MR3, Reuters EUFI.PA, Bloomberg ERF FP). Welcome to health clarity with just a few clicks. View source version on businesswire.com: https://www.businesswire.com/news/home/20201213005051/en/, Plus500. Registration on or use of this site constitutes acceptance of our Terms of Service and Privacy Policy. The GSD NovaPrime® SARS-CoV-2 (COVID-19) is a highly sensitive Multiplex Real-Time PCR test for the direct qualitative pathogen detection of SARS-CoV-2. It is also one of the global independent market leaders in certain testing and laboratory services for genomics, discovery pharmacology, forensics, CDMO, advanced material sciences and in the support of clinical studies. The Group's objective is to provide its customers with high-quality and innovative services, accurate results on time and, when requested, expert advice by its highly-qualified staff. Eurofins Scientific, through its subsidiaries (hereinafter "Eurofins" or "the Group"), believes it is the global leader in food, environmental, pharmaceutical and cosmetics products testing and in agroscience CRO services. Stock quotes by finanzen.net. Disclaimer | Sunny in the afternoon. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and a very large range of testing methods. Available through the Eurofins at-home health testing company, Clinical Enterprise Inc., through its empowerDX business line, the At-Home test can be ordered online (https://empowerdxlab.com/) and will ship to your home or business. COVID cases in India are steadily climbing. Building on the experience and scientific excellence of the Eurofins Group, Eurofins Technologies is a fast growing global provider of diagnostic technologies and industry-leading ELISA-based instruments in the field of bioanalytical testing for the food, feed, environmental, animal health, and clinical diagnostics industries. For further information, please visit the Eurofins Technologies website. COVID-19 : News. (CercleFinance.com) - Eurofins Scientific fait part du lancement en Europe de son test PCR de la Covid-19 avec des options d'auto-échantillonnage à domicile, … The GSD NovaPrime® SARS-CoV-2 (COVID-19) has now been successfully validated for pharynx gargling samples. Eurofins Technologies announces the launch of two important products to support the fight against COVID-19: - a CE-IVD labelled rapid test for the detection of SARS-CoV-2 antigens in 15 minutes; and. FRAMINGHAM, Mass., Dec. 16, 2020 /PRNewswire/ -- Eurofins announces that its FDA-authorized At-Home COVID-19 Nasal PCR Test is now being offered in all 50 states. FRAMINGHAM, Mass., Dec. 16, 2020 /PRNewswire/ -- Eurofins announces that its FDA-authorized At-Home COVID-19 Nasal PCR Test is now being offered in all 50 states.  Previously, the At-Home test was not available for use in New York, New Jersey, Rhode Island and Maryland.  The Emergency Use Authorization ("EUA") authorized self-collection kit gives consumers a minimally invasive, convenient and quick option to test from the comfort of their home.  Results are provided via email link within 24 hours of sample receipt. 1 https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-reference-panel-comparative-data. Eurofins Technologies intends to separately file FDA EUA applications for the new testing modalities. These vials, containing oral or nasal swab samples from players, are part of a big goal: to get LPGA athletes tested for COVID-19 in record time so they can be cleared for each tournament. Useful documents. 07.12.2020 - Regulatory News: Eurofins (Paris:ERF) announces that its FDA-authorized At-Home COVID-19 Nasal PCR Test is now being covered by Medicare, … The At-Home COVID-19 Nasal PCR Test is currently not available for those patients residing in the States of New York, New Jersey, Rhode Island, and Maryland. © 2021 Insider Inc. and finanzen.net GmbH (Imprint). In the Eurofins press release of 9 April 2020Eurofins Technologies announces the launch of a range of testing kits for serology-based antibody detection by ELISA of patients who have been exposed to COVID-19. Eurofins' infectious disease center for excellence, Viracor, developed the test based on its highly sensitive, FDA EUA-authorized SARS-CoV-2 RT-PCR assay.  Viracor's SARS-CoV-2 assay offers the best sensitivity of the 118 laboratories that have submitted results to FDA's SARS-CoV-2 Reference Panel, with a limit of detection of 180 NAAT Detectable Units/mL1. Â. But according to the Daily Telegraph, it was discovered that key components ordered from Eurofins, a company based in Luxembourg, had been contaminated with Covid-19. Non Invasive Prenatal Test by Eurofins Biomnis – NIPT Reliable results from a simple blood test. COVID-19 testing … Eurofins Product Service GmbH - Your partner for the testing and certification of electrical and electronic products! About Eurofins – the global leader in bio-analysis. Cloudy in the morning. Commerce Policy | French diagnostics company Eurofins is launching a new, lower-cost product to detect the presence of SARS-CoV-2 virus responsible for the COVID-19 disease, the company said on Thursday. empowerDX specializes in FDA-authorized COVID-19 testing, women's health, men's health, sexual health and general wellness testing. Eurofins global offer for testing, inspection and certification of products and devices, aimed to serve the increasing demand caused by the coronavirus epidemic.  After completing a questionnaire, qualified consumers will receive the sample collection kit.  Patients who are enrolled in Medicare, Medicaid, or other valid third-party health insurance and meet qualifying COVID-19 exposure and symptomatic criteria, may be eligible for full coverage with no out of pocket costs.  EmpowerDX allows patients to input their insurance information online for a seamless ordering and payment experience, or they can alternatively choose the $99.00 out-of-pocket option.